AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Ricks said at the JPMorgan Healthcare Conference that the government needs to "fix" the Inflation Reduction Act (IRA) before ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

The list of medications covered by Medicare Part ... Medicare has several parts, and they all cover different categories of prescription drugs based on certain criteria. Part D has the broadest ...